Experimental drug aims to help critically ill pneumonia patients breathe easier

NCT ID NCT05962606

Summary

This study tested whether adding the experimental drug AON-D21 to standard pneumonia treatment helps patients with severe pneumonia who need intensive care. Researchers compared AON-D21 against a placebo in 150 hospitalized patients to see if it was safe and helped patients recover faster from breathing support. The main goals were to check for side effects and see if patients could breathe without machines sooner.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMMUNITY ACQUIRED PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Assistance Publique-Hopitaux de Paris (AP-HP)

    Paris, France

  • CHRU de Tours Hôpital Bretonneau

    Tours, France

  • CHU Dupuytren

    Limoges, France

  • Centre Hospitalier Argenteuil

    Argenteuil, France

  • Centre Hospitalier Départemental Vendée

    La Roche-sur-Yon, France

  • Centre Hospitalier de Melun

    Melun, France

  • Charité - Universitätsmedizin Berlin

    Berlin, Germany

  • Clinique Saint Pierre

    Ottignies, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • Cologne-Merheim Hospital Lung Clinic

    Cologne, Germany

  • Hospital Clinico San Carlos

    Madrid, Spain

  • Hospital Doctor Josep Trueta

    Girona, Spain

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spain

  • Hospital Universitari i Politecnic La Fe de Valencia

    Valencia, Spain

  • Hotel Dieu - CHU Nantes

    Nantes, France

  • Hôpital Nord Franche Comté

    Trévenans, France

  • Liverpool University Hospitals NHS Foundation Trust

    Liverpool, United Kingdom

  • Mid Yokshire Teaching NHS Trust

    Wakefield, United Kingdom

  • Nouvel Hôpital Civil

    Strasbourg, France

  • Royal Berkshire Foundation Trust

    Reading, United Kingdom

  • Universitaetsklinikum Giessen und Marburg GmbH

    Giessen, Germany

  • University College London

    London, United Kingdom

  • University Hospital Bristol and Weston NHS

    Bristol, United Kingdom

  • University Hospital of Wales

    Cardiff, United Kingdom

  • University Hospitals Plymouth NHS Trust, Derriford Hospital

    Plymouth, United Kingdom

  • University of Alabama at Birmingham Heersink School of Medicine

    Birmingham, Alabama, 35233, United States

  • York Hospital

    York, United Kingdom

Conditions

Explore the condition pages connected to this study.